Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise
30 October 2025
4 mins read

Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

  • Stock Price: EL traded around $97.36 midday on Oct. 30, 2025 (down ~1.4% on the day)reuters.com. (Shares had jumped ~5% pre-market to ~$102.26 after the earnings release1 .)
  • Sales and Profits: Q1 (ended Sept. 30) net sales of $3.48 B (+4% vs. year‑ago) beat the $3.38 B consensustradingview.com. Organic sales grew ~3%marketscreener.commarketscreener.com. The company swung to profit: GAAP EPS of $0.13 vs. a ($0.43) loss a year earliermarketscreener.com, and adjusted EPS of $0.32 (versus $0.18 expected)tradingview.com2 .
  • Margins Improving: Operating income jumped to $169 M from a $121 M loss (operating margin ~4.9% vs. –3.6% prior year)marketscreener.com. Adjusted operating income rose 77% to $255 M (7.3% margin)marketscreener.com. These gains reflect strong cost-cutting under the “Beauty Reimagined” turnaround program3 .
  • Guidance: Management reaffirmed full-year 2026 targets. It sees GAAP sales growth of roughly 2–5% and organic sales up 0–3%marketscreener.com, with adjusted EPS of $1.90–$2.10benzinga.commarketscreener.com. This implies mid‑single-digit growth and improved profitability despite about $100M in headwinds from tariffsfinimize.com4 .
  • Analyst Outlook: Brokers are largely bullish or neutral. Goldman Sachs just upgraded to Buy and raised its 12-month target to $115 (from $76) on Oct. 13globalcosmeticsnews.com. Canaccord Genuity recently set a $100 targetbenzinga.com. TipRanks shows a consensus price target of ~$99 (high $115, low $82) for ELtipranks.com. About 60% of analysts rate it Buy or Moderate Buy5 .
  • Sector Trends: The beauty/cosmetics industry is rebounding. Travel retail and China demand are recovering – EL’s stock is up ~30% YTDtradingview.com. Peers like Ulta Beauty raised forecasts on steady makeup/skincare demandreuters.com. Luxury brands (e.g. La Mer, Tom Ford) are gaining market share in China and the U.S.marketscreener.com. However, higher tariffs are a risk: EL estimates ~$100M profit hit from trade dutiesfinimize.com6 .
  • Expert Views: RBC Capital Markets’ Nik Modi notes that EL’s better-than-expected margins “show the progress of EL’s PRGP (profit recovery plan) and restructuring activities”reuters.com. Finimize warns that at ~42× forward earnings and with many analysts on “Hold”, the stock’s valuation is highfinimize.com. Analysts caution that ongoing tariffs and an expensive valuation may limit upside despite this strong quarterfinimize.com7 .

Stock Performance Today

Estée Lauder shares jumped in early trading after the earnings release. Reuters data show EL pre-market up ~5% to $102.26tradingview.com. By midday Oct. 30 the stock was about $97.36, down ~1.4% on the dayreuters.com. (Over the past six months, the stock has rallied roughly 60% amid optimism about a rebound in China and travel retailglobalcosmeticsnews.com.) Trading updates noted EL was a top mover on Oct 13 (+6–7%) after Goldman’s upgradets2.techts2.tech. Overall, EL is now up nearly 30% year-to-date8 .

Strong Q1 Results Drive the Rally

The company’s Q1 results far exceeded forecasts. As reported, net sales were $3.481B, up 4% year-over-yearmarketscreener.com (driven by broad strength in skin care, makeup and fragrance). On a non-GAAP (organic) basis, sales rose about 3%marketscreener.commarketscreener.com. This marks a return to growth after two years of decline. Importantly, EL turned profitable: GAAP operating income was $169M versus a $121M loss a year agomarketscreener.com, and GAAP net income was $0.13 per share (versus a $0.43 loss)marketscreener.com. Adjusted EPS of $0.32 beat the consensus of $0.18tradingview.commarketscreener.com. Management credited tight cost controls and efficiency gains from its turnaround program for the margin improvement3 .

Revenues by segment showed notable strength. The Fragrance business saw a ~13% sales jumptradingview.com (led by luxury labels like Le Labo and Tom Ford), helping offset softer trends in some cosmetics lines. Leadership said skin care and core brands like Estée Lauder itself gained market share globallymarketscreener.com. CEO Stéphane de La Faverie highlighted that the quarter’s results “reinforce the confidence we have in our fiscal 2026 outlook” as the company “restore[s] organic sales growth” and expands margins9 .

Analyst Commentary & Price Targets

Financial analysts have responded positively. Goldman Sachs’ Oct. 13 upgrade to Buy (target $115) signaled faith in EL’s China recovery and margin expansionglobalcosmeticsnews.com. Shortly after the earnings, Canaccord Genuity reaffirmed its Hold rating with a $100 targetbenzinga.com. On average, analysts’ 12-month forecasts hover around $99tipranks.com. This implies roughly flat to modest upside from current levels. TipRanks reports that in the past 3 months 17 analysts (out of 24) rate EL as a Buy/Moderate Buy5 .

For context, peers are seeing similar trends: ultrafashion retailer Ulta (not directly comparable but a beauty retail peer) raised its full-year guidance on strong makeup and skincare demandreuters.com. Luxuries like L’Oreal have noted soft U.S. demand but robust Europe/Asia marketsreuters.com. So analysts note that Estée Lauder’s turnaround may continue if tourism (travel retail) and China consumer spending recover.

Industry Trends

Beauty and personal-care stocks have had a mixed year. On the positive side, travel retail (duty-free cosmetics) has started to rebound as pandemic-era travel booms. China – a key market – shows tentative stabilization. Global Cosmetics News notes EL shares gained ~60% over six months as Chinese demand and travel retail reboundedglobalcosmeticsnews.com. Other data indicate rising luxury skincare purchases globally. However, broad consumer caution (due to inflation and tariffs) still hangs over the sector. EL itself warns about up to $100M in tariff costs this yearmarketscreener.comfinimize.com. Finimize reminds investors that despite the beat, Estée Lauder trades at ~42× forward earnings (higher than peers), and many analysts remain “on hold” pending more evidence of sustainable growth7 .

Expert Insights

Financial experts have provided balanced perspectives. RBC Capital Markets analyst Nik Modi praised the operating leverage: “Outperformance on margins shows the progress of EL’s PRGP (Profit Recovery & Growth Plan) and restructuring activities”reuters.com. In other words, cost cuts and efficiency efforts are paying off. However, Finimize cautions that valuation is rich and analysts “are treading carefully”finimize.com. They note EL’s forward P/E is well above the sector average and that most price targets (median near current price) leave little cushionfinimize.comtipranks.com. Going forward, experts say investors will be watching tariff developments closely: management emphasized that they are “actively evaluating” trade policies and have already taken steps to mitigate about half of the tariff impactmarketscreener.com10 .

Outlook and Forecast

Looking ahead, Estée Lauder remains optimistic. The company reaffirmed its FY2026 guidance: roughly 2–5% revenue growth (GAAP) and 0–3% organic growthmarketscreener.com. It expects adjusted EPS in the $1.90–$2.10 rangemarketscreener.com, implying mid-teens profit growth. Institutional sentiment is cautiously positive: many Wall Street strategists see incremental upside, especially if China and travel sales continue to improve. Goldman Sachs, for example, has projected robust margin gains through 2028 on recovering demand11 .

In summary, Estée Lauder’s latest quarter delivered a clear rebound, igniting optimism in the stock. The beat on sales and profit, along with reaffirmed goals, sent the shares higher on Oct. 30tradingview.com. However, analysts note the road ahead still has hurdles (trade costs, premium valuation). For now, investors will watch whether the “Beauty Reimagined” strategy can keep momentum – or if external pressures will slow the comeback.

Sources: Company releases and filingsmarketscreener.commarketscreener.com; financial press and analyst reportstradingview.comglobalcosmeticsnews.comfinimize.comreuters.com. (Full citations provided inline.)

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom
Previous Story

Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors
Next Story

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Go toTop